Title: First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States. | Journal: Antimicrobial agents and chemotherapy. 2008 Jun;52(6):2244-6 | Authors: Mendes RE, Deshpande LM, Castanheira M, DiPersio J, Saubolle MA, Jones RN. | Abstract: Linezolid resistance has dominantly been mediated by mutations in 23S rRNA or ribosomal protein L4 genes. Recently, cfr has demonstrated the ability to produce a phenotype of resistance to not only oxazolidinones, but also other antimicrobial classes (phenicols, lincosamides, pleuromutilins, and streptogramin A). We describe the first detection of cfr-mediated linezolid resistance in Staphylococcus aureus and Staphylococcus epidermidis recovered from human infection cases monitored during the 2007 LEADER Program. | See full PubMed entry: http://www.ncbi.nlm.nih.gov/pubmed/18391032 |
|